Additional 5 Years of AI Treatment Reduces Distant Recurrence Rates Among Postmenopausal Women Already Treated with at Least 5 Years of Endocrine Therapy By Ogkologos - August 25, 2025 555 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a meta-analysis performed by the Early Breast Cancer Trialists’ Collaborative Group Source RELATED ARTICLESMORE FROM AUTHOR Safety and Antitumour Activity of Setidegrasib in Patients with Previously Treated Advanced KRAS p.G12D-mutated NSCLC and PADC EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers MOST POPULAR The Obesity Paradox: It Increases Diabetes Risk But Can Help Cancer... March 13, 2020 FDA Approves Durvalumab with Chemotherapy for Mismatch Repair Deficient Primary Advanced... July 19, 2024 Boy Shaves Head To Support Friend Going Through Cancer October 1, 2021 Mom Gives ‘Elf On The Shelf’ A Wheelchair For Daughter With... December 23, 2021 Load more HOT NEWS We have a Deal: What does the new UK-EU relationship mean... HER2 Is Not a Predictive Biomarker of Benefit From Up-front Chemotherapy... A New FDA Approval Furthers the Role of Genomics in Cancer... Finding Purpose During Cancer: A Survivor’s Story
